Qulipta
Pronunciation: kew-LIP-tah
Generic name: atogepant
Dosage form: oral tablet (10 mg, 30 mg, 60 mg)
Drug class: CGRP inhibitors
What is Qulipta?
Qulipta is used to help prevent episodic and chronic migraine headaches in adults. These are severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light. Qulipta is an oral tablet taken once a day.
Qulipta (atogepant) belongs to a class of medications called CGRP inhibitors.
Qulipta gained FDA approval on September 28, 2021. There is no Qulipta generic available.
How does Qulipta work?
Qulipta's mechanism of action involves blocking the effect of CGRP, a small protein that is highly prevalent in the sensory nerves that supply the head and neck. CGRP is involved in pain transmission, inflammation, and blood vessel dilation, and research has shown levels of CGRP increase during a migraine attack. It may also play a causative role in the initiation of migraine attacks. By blocking CGRP, Qulipta helps prevent migraine headaches (see How does Qulipta work? for more information).
Clinical trials have shown Qulipta starts working within the first week of treatment. Research also shows a 54% reduction in monthly migraine days in patients with episodic migraine and a 36% reduction in patients with chronic migraine headaches (see How well does Qulipta work for migraine?).
Side effects
The most common side effects of Qulipta are:
-
feeling tired/sleepiness.
Serious side effects and warnings
Qulipta may cause the following serious side effects:
- Allergic (hypersensitivity) reactions, including anaphylaxis. Serious allergic reactions can happen when you take Qulipta or days after. Stop taking Qulipta and get emergency medical help right away if you get any of the following symptoms, which may be part of a serious allergic reaction:
- swelling of the face, lips, or tongue
- itching
- trouble breathing
- hives
- rash.
- High blood pressure: High blood pressure or worsening of high blood pressure can happen when you take Qulipta. Contact your healthcare provider if you have an increase in blood pressure.
- Raynaud’s phenomenon: A type of circulation problem can worsen or happen when you take Qulipta. Raynaud’s phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Related/similar drugs
Depakote
Depakote is used to treat various types of seizure disorders. Learn about side effects ...
Botox
Botox is used to treat chronic migraines, excessive sweating, bladder conditions, eye muscle ...
Nurtec ODT
Nurtec ODT (rimegepant) is used to treat acute migraines and prevent episodic migraines, by ...
Topamax
Topamax (topiramate) is used to prevent seizures in adults and children and to prevent migraine ...
Valproic acid
Valproic acid systemic is used for bipolar disorder, cluster-tic syndrome, epilepsy, headache ...
Divalproex sodium
Divalproex sodium systemic is used for bipolar disorder, borderline personality disorder ...
Topiramate
Topiramate systemic is used for bipolar disorder, borderline personality disorder, bulimia ...
Propranolol
Propranolol is a beta-blocker that is used to treat tremors, chest pain, high blood pressure, heart ...
Emgality
Emgality (galcanezumab-gnlm) is a CGRP antagonist for the preventive treatment of migraine and for ...
Before taking this medicine
Do not take Qulipta if you are allergic to atogepant, Qulipta, or any of the inactive ingredients in the tablets.
To make sure Qulipta is safe for you, tell your doctor if you have ever had:
- kidney disease (or if you are on dialysis)
- liver disease
- are pregnant or planning to become pregnant
- are breastfeeding or intend to breastfeed.
Qulipta is not approved for use by anyone younger than 18 years old.
Pregnancy
In animal trials, Qulipta caused pregnancy problems such as low birth weight or birth defects. It is not known if these effects could occur in humans. Ask your doctor about the risk.
Having migraine headaches during pregnancy may increase the risk of dangerously high blood pressure that can lead to medical problems in both mother and baby. The benefit of preventing migraines may outweigh any risk. Tell your doctor if you become pregnant.
Breastfeeding
Ask a doctor if it is safe to breastfeed while using this medicine.
How should I take Qulipta?
Take Qulipta exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets.
- Qulipta is usually taken 1 time daily.
- You may take Qulipta with or without food.
- The dosage of Qulipta depends on what other medications you are currently taking.
Qulipta dosing
Usual Qulipta Adult Dose for Episodic Migraine Prophylaxis:
-
Qulipta 10 mg, 30 mg, or 60 mg orally once a day.
-
The specific dosage depends on how often you get migraines.
- The dosage may need adjusting in severe liver or kidney disease and in those taking interacting medicines.
Usual Qulipta Adult Dose for Chronic Migraine Prophylaxis:
-
Qulipta 60 mg orally once a day.
Qulipta dosage adjustments
Dosage adjustments are needed when Qulipta is taken with certain other medications and for people with severe kidney disease. The table below outlines the recommended Qulipta dosing modifications for drug interactions and specific populations.
Interacting Drug or Condition | Recommended Episodic Migraine Once Daily Dosage | Recommended Chronic Migraine Once Daily Dosage |
Strong CYP3A4 Inhibitors (eg, itraconazole, erythromycin) | 10mg | Avoid use |
Strong, Moderate, or Weak CYP3A4 Inducers (eg, rifampicin) | 30 mg or 60 mg | Avoid use |
OATP Inhibitors (eg, cyclosporine, gemfibrozil) | 10 mg or 60 mg | 30 mg |
Severe Renal Impairment and End-Stage Renal Disease (CLcr <30 mL/min) | 10 mg | Avoid use |
Qulipta cost
The cost of Qulipta depends on your insurance and the pharmacy you use. With the Qulipta Complete Savings Card, eligible commercially insured patients may pay as little as $0.
This Qulipta co-pay assistance program is not available to patients receiving prescription reimbursement under Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs, or where prohibited by law. Call 1-855-QULIPTA for additional information.
For more information see Qulipta Prices, Coupons, Copay Cards & Patient Assistance.
What happens if I miss a dose?
Take the medicine as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not take two doses at one time.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while taking Qulipta?
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
What other drugs will affect Qulipta?
Tell your doctor about all your current medicines. Many drugs can affect atogepant, especially:
-
an antibiotic such as clarithromycin or rifampin;
-
antifungal medicine such as itraconazole or ketoconazole;
-
antiviral medicine to treat HIV, such as efavirenz or etravirine; or
-
seizure medicine such as carbamazepine or phenytoin.
This list is not complete and many other drugs may affect Qulipta. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Qulipta ingredients
Active ingredient: atogepant
Inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, mannitol, microcrystalline cellulose, polyvinylpyrrolidone vinyl acetate copolymer, sodium chloride, sodium stearyl fumarate, and vitamin E polyethylene glycol succinate.
Qulipta is supplied as 10 mg, 30 mg, and 60 mg tablets.
Storage
Store Qulipta at room temperature away from moisture and heat.
Who makes Qulipta?
Qulipta (atogepant) is made by AbbVie, headquartered in North Chicago, Illinois.
Key medications in AbbVie's portfolio include:
- Humira (arthritis, psoriasis)
- Botox (cosmetic and therapeutic uses)
- Vraylar (schizophrenia, bipolar)
- Rinvoq (arthritis)
- Skyrizi (psoriasis)
- Ubrelvy (migraine).
Note that AbbVie acquired many of these medications through their 2020 acquisition of Allergan.
Popular FAQ
How do Ubrelvy, Qulipta and Nurtec compare for migraines?
Ubrelvy, Qulipta and Nurtec ODT are all medicines used by adults for migraines. They are all from the same group of medicines often called gepants but their full name is calcitonin gene-related peptide (CGRP) receptor antagonist. Continue reading
Does Qulipta cause weight loss?
Yes, you may lose some weight if you are taking Qulipta. Weight loss was observed in all Qulipta studies, which included over 2,600 people. Results showed that 3.2% to 5.3% of patients taking Qulipta lost at least 7% of their body weight, compared to 2.5% of those taking a pill with no medicine (placebo). Weight loss may occur due to nausea and loss of appetite. Continue reading
How long does Qulipta take to work?
Qulipta can begin working on the first day of treatment to help prevent your episodic migraine headaches. Researchers observed that 88% (185 / 211) patients did not have a migraine the day after taking a Qulipta 60 mg dose, compared to 75% (151 / 202) taking an inactive placebo pill. Continue reading
When is the best time of the day to take Qulipta?
Take your prescribed dose each day at about the same time, with or without food. Some people feel tired or sleepy when taking Qulipta. If this occurs, ask your healthcare provider if you can take your dose at bedtime. If you feel nauseous, take your daily dose at mealtime. Continue reading
Does Qulipta (atogepant) cause hair loss?
No, hair loss is not a reported side effect of Qulipta from clinical trials and is not in the package insert. Reports suggest that alopecia (hair loss) is an emerging side effect with certain CGRP inhibitor migraine medicines, although larger, more adequately controlled studies are needed. Continue reading
How well does Qulipta work for migraine?
Qulipta, a preventive migraine treatment, has been shown in studies to lead to a 54% reduction in monthly migraine days in patients with episodic migraine (a 4.2-day reduction) and a 36% reduction in patients with chronic migraine headaches (a 6.9-day reduction). Continue reading
How does Qulipta work?
Qulipta works by blocking a key protein in your body called calcitonin-related gene peptide, or CGRP, to help prevent migraine headaches and the transmission of pain. Qulipta belongs to the gepant class of CGRP receptor antagonists and is given orally once per day for episodic or chronic migraines. Continue reading
More FAQ
More about Qulipta (atogepant)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (174)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- FDA approval history
- Drug class: CGRP inhibitors
- Breastfeeding
- En español
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.